Numerion Labs
PrivateLast Round
Early Stage
VC
Mar 10, 2026
Est. Valuation
$1.71M
Total Funding Raised
$221.42M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Numerion Labs operates in AI, Data & Cloud Infrastructure and is based in San Francisco, California. Its latest recorded funding round was a Series C round in March 2024.
Numerion Labs is a biotechnology company that develops an artificial intelligence-driven platform for small molecule drug discovery.
Sector
AI, Data & Cloud Infrastructure
Verticals
Business Intelligence, Data Integration, ML Platforms, NLP & Conversational AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Numerion Labs Comparables
Compare Numerion Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iambic Therapeutics | 79% | |
| Insilico Medicine | 78% | |
| Terray Therapeutics | 77% |
For institutional investors. Book with your work email.
Numerion Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Mar 10, 2026 | ||||
| Series C | Mar 1, 2024 | ||||
| Grant | Oct 6, 2020 | ||||
| Series B | Aug 11, 2020 | ||||
| Series A | Mar 7, 2018 | ||||
Seed | Jun 3, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Numerion Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sanabil Investments | Series B |
| Threshold Ventures | Seed |
| Dolby Family Ventures | Series A, Series B |
| B Capital Group | Series C, Series A, Series B |
| Khosla Ventures | Series A, Seed, Series C |
| BV Investment Partners | Series B |
| Baidu Ventures | Series A, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 47% MoM.
- Mar 10, 2026
$20M raised in early stage VC round.
For institutional investors. Book with your work email.
Numerion Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Numerion Labs's valuation, stock price, and market status.
Is Numerion Labs a public or private company?
Numerion Labs is a private company.
What is the current stock price of Numerion Labs?
Numerion Labs is a private company, so its shares have no public market price. Caplight tracks Numerion Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Numerion Labs worth (valuation)?
Numerion Labs's valuation is estimated at $1.7M based on funding round data.
Can I buy Numerion Labs stock?
Numerion Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Numerion Labs's last funding round?
Numerion Labs's most recent funding round was Early Stage VC on March 10, 2026.
Who are the main investors in Numerion Labs?
Key investors in Numerion Labs include Sanabil Investments, B Capital Group, Khosla Ventures, Y Combinator, Leaps by Bayer.
Will Numerion Labs IPO soon?
No public IPO plans have been announced for Numerion Labs.
How can I track Numerion Labs secondary market activity?
Caplight tracks bids, offers, and trades in Numerion Labs's shares on secondary markets.